Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 75.21% is 38% above its 5-year average of 54.58%, around the middle of its 5-year range (40.46%–92.40%).
3.39% above its 12-month average of 72.75%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2027 (2026-07-31): 73.55%.
GROSS MARGIN
75.21%
GROSS MARGIN AVG TTM
72.75%
GROSS MARGIN AVG 3Y
58.93%
GROSS MARGIN AVG 5Y
54.58%
GROSS MARGIN AVG 10Y
54.81%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.39%
CURRENT VS 3Y AVG
+27.62%
CURRENT VS 5Y AVG
+37.81%
CURRENT VS 10Y AVG
+37.21%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 616 covered companies
CURRENT VS SECTOR MEDIAN
+75.27%
vs the sector median at left
Market Cap
$7.61B
Gross Margin
84.97%
TTM Avg
-824.36%
3Y Avg
-1521.85%
5Y Avg
-1048.03%
Market Cap
$7.29B
Gross Margin
98.16%
TTM Avg
98.36%
3Y Avg
98.29%
5Y Avg
98.36%
Market Cap
$8.14B
Gross Margin
69.66%
TTM Avg
54.89%
3Y Avg
42.48%
5Y Avg
46.51%
Market Cap
$8.39B
Gross Margin
101.98%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HealthEquity, Inc. (HQY) | $7.59B | 75.21% | 72.75% | 58.93% | 54.58% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.61B | 84.97% | -824.36% | -1521.85% | -1048.03% |
| Hinge Health, Inc. (HNGE)vs › | $7.51B | 84.52% | 78.41% | 74.39% | 74.39% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.29B | 98.16% | 98.36% | 98.29% | 98.36% |
| Caris Life Sciences, Inc. (CAI)vs › | $8.14B | 69.66% | 54.89% | 42.48% | 46.51% |
| Alkermes plc (ALKS)vs › | $6.93B | 84.56% | 85.47% | 84.03% | 83.69% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.39B | 101.98% | 100.00% | 100.00% | 100.00% |
| Oscar Health, Inc. (OSCR)vs › | $8.47B | 14.38% | 17.24% | 38.82% | 59.22% |
| Chemed Corporation (CHE)vs › | $6.67B | 30.44% | 32.55% | 34.06% | 34.32% |
| Immunovant, Inc. (IMVT)vs › | $6.63B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
75.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-31 | 73.55% |
| 2026-04-30 | 72.27% |
| 2026-01-31 | 92.40% |
| 2025-10-31 | 62.41% |
| 2025-07-31 | 63.10% |
| 2025-04-30 | 59.64% |
| 2025-01-31 | 60.69% |
| 2024-10-31 | 56.14% |
| 2024-07-31 | 57.70% |
| 2024-04-30 | 56.19% |
| 2024-01-31 | 53.40% |
| 2023-10-31 | 54.25% |
| 2023-07-31 | 52.46% |
| 2023-04-30 | 51.00% |
| 2023-01-31 | 47.50% |
| 2022-10-31 | 47.81% |
| 2022-07-31 | 45.42% |
| 2022-04-30 | 42.53% |
| 2022-01-31 | 40.46% |
| 2021-10-31 | 46.50% |
| 2021-07-31 | 48.48% |
| 2021-04-30 | 45.22% |
| 2021-01-31 | 43.45% |
| 2020-10-31 | 47.63% |
| 2020-07-31 | 46.98% |
| 2020-04-30 | 47.04% |
| 2020-01-31 | 47.22% |
| 2019-10-31 | 52.82% |
| 2019-07-31 | 65.74% |
| 2019-04-30 | 64.63% |
| 2019-01-31 | 56.68% |
| 2018-10-31 | 62.88% |
| 2018-07-31 | 63.46% |
| 2018-04-30 | 61.35% |
| 2018-01-31 | 49.81% |
| 2017-10-31 | 57.36% |
| 2017-07-31 | 61.04% |
| 2017-04-30 | 58.93% |
| 2017-01-31 | 49.44% |
| 2016-10-31 | 57.22% |
| 2016-07-31 | 62.17% |
| 2016-04-30 | 62.89% |
| 2016-01-31 | 51.36% |
| 2015-10-31 | 57.85% |
| 2015-07-31 | 60.95% |
| 2015-04-30 | 59.99% |
| 2015-01-31 | 50.31% |
| 2014-10-31 | 55.95% |
| 2014-07-31 | 56.34% |
| 2014-04-30 | 56.64% |
| 2014-01-31 | 49.08% |
| 2013-10-31 | 54.94% |
| 2013-07-31 | 55.69% |
| 2013-04-30 | 52.37% |
